2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Ami P. Vaidya, MD, discusses advances in the management of endometrial cancer.
Ami P. Vaidya, MD, vice chair, Department of Obstetrics and Gynecology, co-chief, Division of Gynecologic Oncology, director, Robotics, Gynecology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, discusses advances in the management of endometrial cancer.
The integration of minimally invasive surgery into the treatment paradigm of endometrial cancer has significantly decreased postoperative healing time for patients, Vaidya says. Additionally, patient testimonials, as well as clinical data, have demonstrated that minimally invasive surgery decreases postoperative pain, decreases time spent in the hospital, and shortens recovery time overall.
Sentinel lymph node biopsy has also been a significant advancement in the field of endometrial cancer. Long-term data are beginning to show decreased rates of lymphedema on the order of 5% vs 30% in patients who underwent sentinel lymph node identification, Vaidya concludes.